Cipla has appointed Dr. R Ananthanarayanan as its global chief operating officer. In his new role, Ananthanarayanan will oversee R&D, manufacturing, supply chain, the API business and the key geographies of North America, Europe and Emerging Markets at Cipla. Prior to this appointment, Ananthanarayanan worked for Teva Pharmaceutical Industries Ltd. as its president and chief executive officer, Teva API & Biologics.